Candel Therapeutics, Inc.

CADL·NASDAQ·$7.95Share Price as of 11/2·$436MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/14/26 10-KFY 202503/12/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report09/10/26 8-KCurrent report09/09/26 8-KCurrent report08/13/26 8-KCurrent report06/24/26 8-KCurrent report06/16/26

Prospectuses and Registrations

S-8Registration of securities for employees03/12/26 424B5Prospectus supplement02/20/26 424B5Prospectus supplement02/19/26 S-3Shelf registration08/14/25 424B5Prospectus supplement06/24/25

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25 DEF 14ADefinitive proxy05/30/24

Ownership

Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26 Form 4Insider transaction09/11/26 144Proposed sale of securities09/10/26

Other

ARSAnnual report to shareholders04/29/26 EFFECTRequest for effectiveness08/22/25 CORRESPCorrespondence with the SEC08/20/25 UPLOADLetter from the SEC08/20/25 ARSAnnual report to shareholders04/29/25